Marker Therapeutics (MRKR) vs Neuphoria Therapeutics (NEUP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Marker Therapeutics (MRKR) has outperformed Neuphoria Therapeutics (NEUP) over the past year, losing 1.9% versus a loss of 81.8%. Neuphoria Therapeutics is the larger company by market cap ($18.5 million vs $17.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MRKR | NEUP |
|---|---|---|
| Share price | $1.03 | $3.42 |
| Market cap | $17.13M | $18.51M |
| 1-day change | -1.21% | 0.00% |
| YTD return | -30.20% | -11.86% |
| 1-year return | -1.89% | -81.78% |
| 5-year return | -93.46% | — |
| EPS (TTM) | $-0.42 | $-3.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.46 | $19.21 |
| 52-week low | $0.84 | $3.19 |
| Distance from 52-week high | -58.24% | -82.20% |
| Average volume | 64.80K | 162.11K |
| Shares outstanding | 16.67M | 5.41M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MRKR has outperformed NEUP by 79.9 percentage points over the past year.
MRKR vs NEUP FAQ
Which is bigger, Marker Therapeutics or Neuphoria Therapeutics?
Neuphoria Therapeutics (NEUP) is larger, with a market capitalization of $18.51M compared with $17.13M for Marker Therapeutics (MRKR).
Which stock has performed better over the past year, MRKR or NEUP?
MRKR returned -1.89% over the past 12 months, compared with -81.78% for NEUP (price return, excluding dividends). Past performance does not predict future results.
Are Marker Therapeutics and Neuphoria Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.